nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—XDH—Effects of Nitric Oxide—NOS1—asthma	0.0095	0.161	CbGpPWpGaD
Deferoxamine—XDH—Purine catabolism—CAT—asthma	0.00654	0.111	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—NOS2—asthma	0.00566	0.096	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—NOS3—asthma	0.00455	0.0772	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—CYBA—asthma	0.00358	0.0608	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—NQO1—asthma	0.00335	0.0568	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—HMOX1—asthma	0.00275	0.0467	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—CAT—asthma	0.00272	0.0461	CbGpPWpGaD
Deferoxamine—XDH—Purine metabolism—CAT—asthma	0.00252	0.0427	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ALOX5AP—asthma	0.0023	0.039	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ALOX5—asthma	0.00196	0.0332	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—CAT—asthma	0.00126	0.0215	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CAT—asthma	0.00115	0.0195	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CRP—asthma	0.000912	0.0155	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ICAM1—asthma	0.000838	0.0142	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CCL2—asthma	0.00075	0.0127	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SERPINE1—asthma	0.0007	0.0119	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ALB—asthma	0.000699	0.0119	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—IFNG—asthma	0.000638	0.0108	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—PTGS2—asthma	0.000611	0.0104	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—IL1B—asthma	0.000569	0.00965	CbGpPWpGaD
Deferoxamine—Visual impairment—Prednisolone—asthma	0.000475	0.000504	CcSEcCtD
Deferoxamine—Connective tissue disorder—Hydrocortisone—asthma	0.000473	0.000502	CcSEcCtD
Deferoxamine—Vomiting—Flunisolide—asthma	0.000472	0.000501	CcSEcCtD
Deferoxamine—Diarrhoea—Mometasone—asthma	0.000471	0.0005	CcSEcCtD
Deferoxamine—Urticaria—Budesonide—asthma	0.000469	0.000499	CcSEcCtD
Deferoxamine—Body temperature increased—Budesonide—asthma	0.000467	0.000496	CcSEcCtD
Deferoxamine—Abdominal pain—Budesonide—asthma	0.000467	0.000496	CcSEcCtD
Deferoxamine—Hypersensitivity—Montelukast—asthma	0.000466	0.000495	CcSEcCtD
Deferoxamine—Headache—Flunisolide—asthma	0.000465	0.000494	CcSEcCtD
Deferoxamine—Bradycardia—Triamcinolone—asthma	0.000461	0.00049	CcSEcCtD
Deferoxamine—Bradycardia—Methylprednisolone—asthma	0.00046	0.000489	CcSEcCtD
Deferoxamine—Pruritus—Arformoterol—asthma	0.000457	0.000486	CcSEcCtD
Deferoxamine—Pruritus—Formoterol—asthma	0.000457	0.000486	CcSEcCtD
Deferoxamine—Hallucination—Methylprednisolone—asthma	0.00045	0.000478	CcSEcCtD
Deferoxamine—Eye disorder—Hydrocortisone—asthma	0.00045	0.000478	CcSEcCtD
Deferoxamine—Hypersensitivity—Salbutamol—asthma	0.000449	0.000478	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Dexamethasone—asthma	0.000449	0.000477	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Betamethasone—asthma	0.000449	0.000477	CcSEcCtD
Deferoxamine—Pruritus—Montelukast—asthma	0.000448	0.000476	CcSEcCtD
Deferoxamine—Connective tissue disorder—Methylprednisolone—asthma	0.000444	0.000472	CcSEcCtD
Deferoxamine—Diarrhoea—Arformoterol—asthma	0.000442	0.00047	CcSEcCtD
Deferoxamine—Diarrhoea—Formoterol—asthma	0.000442	0.00047	CcSEcCtD
Deferoxamine—Nausea—Flunisolide—asthma	0.000441	0.000468	CcSEcCtD
Deferoxamine—Arrhythmia—Prednisolone—asthma	0.00044	0.000468	CcSEcCtD
Deferoxamine—Vomiting—Mometasone—asthma	0.000438	0.000465	CcSEcCtD
Deferoxamine—Visual impairment—Methylprednisolone—asthma	0.000435	0.000463	CcSEcCtD
Deferoxamine—Hypersensitivity—Budesonide—asthma	0.000435	0.000463	CcSEcCtD
Deferoxamine—Immune system disorder—Hydrocortisone—asthma	0.000434	0.000462	CcSEcCtD
Deferoxamine—Diarrhoea—Montelukast—asthma	0.000433	0.00046	CcSEcCtD
Deferoxamine—Pruritus—Salbutamol—asthma	0.000432	0.000459	CcSEcCtD
Deferoxamine—Headache—Mometasone—asthma	0.000431	0.000458	CcSEcCtD
Deferoxamine—Arrhythmia—Hydrocortisone—asthma	0.00043	0.000457	CcSEcCtD
Deferoxamine—Erythema—Prednisolone—asthma	0.000429	0.000456	CcSEcCtD
Deferoxamine—Dizziness—Formoterol—asthma	0.000427	0.000454	CcSEcCtD
Deferoxamine—Dizziness—Arformoterol—asthma	0.000427	0.000454	CcSEcCtD
Deferoxamine—XDH—Metabolism—LTC4S—asthma	0.000423	0.00717	CbGpPWpGaD
Deferoxamine—Eye disorder—Methylprednisolone—asthma	0.000422	0.000449	CcSEcCtD
Deferoxamine—Erythema—Hydrocortisone—asthma	0.000419	0.000445	CcSEcCtD
Deferoxamine—Dizziness—Montelukast—asthma	0.000418	0.000445	CcSEcCtD
Deferoxamine—Bradycardia—Dexamethasone—asthma	0.000418	0.000445	CcSEcCtD
Deferoxamine—Bradycardia—Betamethasone—asthma	0.000418	0.000445	CcSEcCtD
Deferoxamine—Pruritus—Budesonide—asthma	0.000418	0.000444	CcSEcCtD
Deferoxamine—Diarrhoea—Salbutamol—asthma	0.000417	0.000444	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—TNF—asthma	0.000413	0.007	CbGpPWpGaD
Deferoxamine—Vomiting—Formoterol—asthma	0.000411	0.000437	CcSEcCtD
Deferoxamine—Vomiting—Arformoterol—asthma	0.000411	0.000437	CcSEcCtD
Deferoxamine—Angiopathy—Methylprednisolone—asthma	0.00041	0.000436	CcSEcCtD
Deferoxamine—Hallucination—Dexamethasone—asthma	0.000409	0.000435	CcSEcCtD
Deferoxamine—Hallucination—Betamethasone—asthma	0.000409	0.000435	CcSEcCtD
Deferoxamine—Nausea—Mometasone—asthma	0.000409	0.000434	CcSEcCtD
Deferoxamine—Immune system disorder—Methylprednisolone—asthma	0.000408	0.000434	CcSEcCtD
Deferoxamine—Mediastinal disorder—Methylprednisolone—asthma	0.000407	0.000433	CcSEcCtD
Deferoxamine—Headache—Arformoterol—asthma	0.000405	0.00043	CcSEcCtD
Deferoxamine—Headache—Formoterol—asthma	0.000405	0.00043	CcSEcCtD
Deferoxamine—Arrhythmia—Triamcinolone—asthma	0.000405	0.00043	CcSEcCtD
Deferoxamine—Diarrhoea—Budesonide—asthma	0.000404	0.00043	CcSEcCtD
Deferoxamine—Vision blurred—Prednisolone—asthma	0.000404	0.000429	CcSEcCtD
Deferoxamine—Arrhythmia—Methylprednisolone—asthma	0.000404	0.000429	CcSEcCtD
Deferoxamine—Dizziness—Salbutamol—asthma	0.000403	0.000429	CcSEcCtD
Deferoxamine—Vomiting—Montelukast—asthma	0.000402	0.000428	CcSEcCtD
Deferoxamine—Headache—Montelukast—asthma	0.000396	0.000421	CcSEcCtD
Deferoxamine—Visual impairment—Dexamethasone—asthma	0.000396	0.000421	CcSEcCtD
Deferoxamine—Visual impairment—Betamethasone—asthma	0.000396	0.000421	CcSEcCtD
Deferoxamine—Erythema—Triamcinolone—asthma	0.000394	0.000419	CcSEcCtD
Deferoxamine—Erythema—Methylprednisolone—asthma	0.000393	0.000418	CcSEcCtD
Deferoxamine—Angioedema—Prednisolone—asthma	0.000392	0.000416	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Prednisone—asthma	0.000391	0.000415	CcSEcCtD
Deferoxamine—Dizziness—Budesonide—asthma	0.000391	0.000415	CcSEcCtD
Deferoxamine—Vomiting—Salbutamol—asthma	0.000388	0.000412	CcSEcCtD
Deferoxamine—Eye disorder—Betamethasone—asthma	0.000384	0.000408	CcSEcCtD
Deferoxamine—Eye disorder—Dexamethasone—asthma	0.000384	0.000408	CcSEcCtD
Deferoxamine—Nausea—Arformoterol—asthma	0.000384	0.000408	CcSEcCtD
Deferoxamine—Nausea—Formoterol—asthma	0.000384	0.000408	CcSEcCtD
Deferoxamine—Angioedema—Hydrocortisone—asthma	0.000383	0.000407	CcSEcCtD
Deferoxamine—Headache—Salbutamol—asthma	0.000382	0.000406	CcSEcCtD
Deferoxamine—Nausea—Montelukast—asthma	0.000376	0.000399	CcSEcCtD
Deferoxamine—Vomiting—Budesonide—asthma	0.000376	0.000399	CcSEcCtD
Deferoxamine—Angiopathy—Dexamethasone—asthma	0.000373	0.000396	CcSEcCtD
Deferoxamine—Angiopathy—Betamethasone—asthma	0.000373	0.000396	CcSEcCtD
Deferoxamine—Convulsion—Prednisolone—asthma	0.000371	0.000395	CcSEcCtD
Deferoxamine—Headache—Budesonide—asthma	0.00037	0.000393	CcSEcCtD
Deferoxamine—Arrhythmia—Dexamethasone—asthma	0.000367	0.00039	CcSEcCtD
Deferoxamine—Arrhythmia—Betamethasone—asthma	0.000367	0.00039	CcSEcCtD
Deferoxamine—XDH—Metabolism—LTA4H—asthma	0.000367	0.00622	CbGpPWpGaD
Deferoxamine—Bradycardia—Prednisone—asthma	0.000364	0.000387	CcSEcCtD
Deferoxamine—Convulsion—Hydrocortisone—asthma	0.000363	0.000386	CcSEcCtD
Deferoxamine—Nausea—Salbutamol—asthma	0.000362	0.000385	CcSEcCtD
Deferoxamine—Angioedema—Triamcinolone—asthma	0.00036	0.000383	CcSEcCtD
Deferoxamine—Angioedema—Methylprednisolone—asthma	0.000359	0.000382	CcSEcCtD
Deferoxamine—Erythema—Betamethasone—asthma	0.000358	0.00038	CcSEcCtD
Deferoxamine—Erythema—Dexamethasone—asthma	0.000358	0.00038	CcSEcCtD
Deferoxamine—Myalgia—Hydrocortisone—asthma	0.000356	0.000379	CcSEcCtD
Deferoxamine—Hallucination—Prednisone—asthma	0.000356	0.000378	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	0.000354	0.000376	CcSEcCtD
Deferoxamine—Connective tissue disorder—Prednisone—asthma	0.000352	0.000374	CcSEcCtD
Deferoxamine—Nausea—Budesonide—asthma	0.000351	0.000373	CcSEcCtD
Deferoxamine—Oedema—Prednisolone—asthma	0.00035	0.000372	CcSEcCtD
Deferoxamine—Anaphylactic shock—Prednisolone—asthma	0.00035	0.000372	CcSEcCtD
Deferoxamine—Shock—Prednisolone—asthma	0.000344	0.000366	CcSEcCtD
Deferoxamine—Oedema—Hydrocortisone—asthma	0.000342	0.000363	CcSEcCtD
Deferoxamine—Anaphylactic shock—Hydrocortisone—asthma	0.000342	0.000363	CcSEcCtD
Deferoxamine—Convulsion—Triamcinolone—asthma	0.000342	0.000363	CcSEcCtD
Deferoxamine—Tachycardia—Prednisolone—asthma	0.000341	0.000363	CcSEcCtD
Deferoxamine—Convulsion—Methylprednisolone—asthma	0.000341	0.000362	CcSEcCtD
Deferoxamine—Infection—Hydrocortisone—asthma	0.00034	0.000361	CcSEcCtD
Deferoxamine—Shock—Hydrocortisone—asthma	0.000336	0.000357	CcSEcCtD
Deferoxamine—Myalgia—Triamcinolone—asthma	0.000336	0.000357	CcSEcCtD
Deferoxamine—Nervous system disorder—Hydrocortisone—asthma	0.000335	0.000356	CcSEcCtD
Deferoxamine—Arthralgia—Methylprednisolone—asthma	0.000335	0.000356	CcSEcCtD
Deferoxamine—Myalgia—Methylprednisolone—asthma	0.000335	0.000356	CcSEcCtD
Deferoxamine—Eye disorder—Prednisone—asthma	0.000334	0.000355	CcSEcCtD
Deferoxamine—Tachycardia—Hydrocortisone—asthma	0.000334	0.000354	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—IL6—asthma	0.000333	0.00565	CbGpPWpGaD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	0.000333	0.000353	CcSEcCtD
Deferoxamine—Skin disorder—Hydrocortisone—asthma	0.000332	0.000353	CcSEcCtD
Deferoxamine—Angioedema—Dexamethasone—asthma	0.000327	0.000347	CcSEcCtD
Deferoxamine—Angioedema—Betamethasone—asthma	0.000327	0.000347	CcSEcCtD
Deferoxamine—Angiopathy—Prednisone—asthma	0.000325	0.000345	CcSEcCtD
Deferoxamine—Immune system disorder—Prednisone—asthma	0.000323	0.000344	CcSEcCtD
Deferoxamine—Anaphylactic shock—Triamcinolone—asthma	0.000322	0.000342	CcSEcCtD
Deferoxamine—Oedema—Triamcinolone—asthma	0.000322	0.000342	CcSEcCtD
Deferoxamine—Anaphylactic shock—Methylprednisolone—asthma	0.000321	0.000341	CcSEcCtD
Deferoxamine—XDH—Metabolism—ARG1—asthma	0.000321	0.00544	CbGpPWpGaD
Deferoxamine—Arrhythmia—Prednisone—asthma	0.00032	0.00034	CcSEcCtD
Deferoxamine—Infection—Triamcinolone—asthma	0.00032	0.00034	CcSEcCtD
Deferoxamine—Hypotension—Hydrocortisone—asthma	0.000319	0.000339	CcSEcCtD
Deferoxamine—Infection—Methylprednisolone—asthma	0.000319	0.000339	CcSEcCtD
Deferoxamine—Shock—Triamcinolone—asthma	0.000317	0.000336	CcSEcCtD
Deferoxamine—Shock—Methylprednisolone—asthma	0.000316	0.000336	CcSEcCtD
Deferoxamine—Nervous system disorder—Methylprednisolone—asthma	0.000315	0.000335	CcSEcCtD
Deferoxamine—Paraesthesia—Prednisolone—asthma	0.000314	0.000334	CcSEcCtD
Deferoxamine—Tachycardia—Triamcinolone—asthma	0.000314	0.000334	CcSEcCtD
Deferoxamine—Tachycardia—Methylprednisolone—asthma	0.000313	0.000333	CcSEcCtD
Deferoxamine—Skin disorder—Methylprednisolone—asthma	0.000312	0.000331	CcSEcCtD
Deferoxamine—Erythema—Prednisone—asthma	0.000312	0.000331	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Hydrocortisone—asthma	0.000311	0.000331	CcSEcCtD
Deferoxamine—Convulsion—Betamethasone—asthma	0.00031	0.000329	CcSEcCtD
Deferoxamine—Convulsion—Dexamethasone—asthma	0.00031	0.000329	CcSEcCtD
Deferoxamine—Paraesthesia—Hydrocortisone—asthma	0.000307	0.000326	CcSEcCtD
Deferoxamine—Myalgia—Betamethasone—asthma	0.000305	0.000324	CcSEcCtD
Deferoxamine—Myalgia—Dexamethasone—asthma	0.000305	0.000324	CcSEcCtD
Deferoxamine—Hypotension—Methylprednisolone—asthma	0.0003	0.000319	CcSEcCtD
Deferoxamine—Pain—Prednisolone—asthma	0.000299	0.000318	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Hydrocortisone—asthma	0.000295	0.000314	CcSEcCtD
Deferoxamine—Vision blurred—Prednisone—asthma	0.000294	0.000312	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Triamcinolone—asthma	0.000293	0.000312	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Methylprednisolone—asthma	0.000293	0.000311	CcSEcCtD
Deferoxamine—Pain—Hydrocortisone—asthma	0.000292	0.000311	CcSEcCtD
Deferoxamine—Anaphylactic shock—Betamethasone—asthma	0.000292	0.00031	CcSEcCtD
Deferoxamine—Anaphylactic shock—Dexamethasone—asthma	0.000292	0.00031	CcSEcCtD
Deferoxamine—Oedema—Betamethasone—asthma	0.000292	0.00031	CcSEcCtD
Deferoxamine—Oedema—Dexamethasone—asthma	0.000292	0.00031	CcSEcCtD
Deferoxamine—Infection—Betamethasone—asthma	0.00029	0.000308	CcSEcCtD
Deferoxamine—Infection—Dexamethasone—asthma	0.00029	0.000308	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALDH7A1—asthma	0.00029	0.00492	CbGpPWpGaD
Deferoxamine—Paraesthesia—Triamcinolone—asthma	0.000289	0.000307	CcSEcCtD
Deferoxamine—Paraesthesia—Methylprednisolone—asthma	0.000288	0.000306	CcSEcCtD
Deferoxamine—Shock—Dexamethasone—asthma	0.000287	0.000305	CcSEcCtD
Deferoxamine—Shock—Betamethasone—asthma	0.000287	0.000305	CcSEcCtD
Deferoxamine—Dyspnoea—Triamcinolone—asthma	0.000287	0.000305	CcSEcCtD
Deferoxamine—Nervous system disorder—Betamethasone—asthma	0.000286	0.000304	CcSEcCtD
Deferoxamine—Nervous system disorder—Dexamethasone—asthma	0.000286	0.000304	CcSEcCtD
Deferoxamine—Thrombocytopenia—Dexamethasone—asthma	0.000286	0.000304	CcSEcCtD
Deferoxamine—Thrombocytopenia—Betamethasone—asthma	0.000286	0.000304	CcSEcCtD
Deferoxamine—Tachycardia—Dexamethasone—asthma	0.000285	0.000303	CcSEcCtD
Deferoxamine—Tachycardia—Betamethasone—asthma	0.000285	0.000303	CcSEcCtD
Deferoxamine—Angioedema—Prednisone—asthma	0.000285	0.000303	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Hydrocortisone—asthma	0.000279	0.000297	CcSEcCtD
Deferoxamine—Urticaria—Prednisolone—asthma	0.000278	0.000295	CcSEcCtD
Deferoxamine—XDH—Metabolism—ARG2—asthma	0.000278	0.00471	CbGpPWpGaD
Deferoxamine—Pain—Triamcinolone—asthma	0.000275	0.000292	CcSEcCtD
Deferoxamine—Hypotension—Dexamethasone—asthma	0.000273	0.00029	CcSEcCtD
Deferoxamine—Hypotension—Betamethasone—asthma	0.000273	0.00029	CcSEcCtD
Deferoxamine—Urticaria—Hydrocortisone—asthma	0.000271	0.000288	CcSEcCtD
Deferoxamine—Abdominal pain—Hydrocortisone—asthma	0.00027	0.000287	CcSEcCtD
Deferoxamine—Body temperature increased—Hydrocortisone—asthma	0.00027	0.000287	CcSEcCtD
Deferoxamine—Convulsion—Prednisone—asthma	0.00027	0.000287	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Dexamethasone—asthma	0.000266	0.000283	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Betamethasone—asthma	0.000266	0.000283	CcSEcCtD
Deferoxamine—Myalgia—Prednisone—asthma	0.000265	0.000282	CcSEcCtD
Deferoxamine—Arthralgia—Prednisone—asthma	0.000265	0.000282	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	0.000263	0.00028	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Methylprednisolone—asthma	0.000263	0.000279	CcSEcCtD
Deferoxamine—Paraesthesia—Dexamethasone—asthma	0.000262	0.000279	CcSEcCtD
Deferoxamine—Paraesthesia—Betamethasone—asthma	0.000262	0.000279	CcSEcCtD
Deferoxamine—Hypersensitivity—Prednisolone—asthma	0.000258	0.000274	CcSEcCtD
Deferoxamine—Urticaria—Triamcinolone—asthma	0.000256	0.000272	CcSEcCtD
Deferoxamine—Urticaria—Methylprednisolone—asthma	0.000255	0.000271	CcSEcCtD
Deferoxamine—Body temperature increased—Triamcinolone—asthma	0.000254	0.00027	CcSEcCtD
Deferoxamine—Oedema—Prednisone—asthma	0.000254	0.00027	CcSEcCtD
Deferoxamine—Anaphylactic shock—Prednisone—asthma	0.000254	0.00027	CcSEcCtD
Deferoxamine—Abdominal pain—Methylprednisolone—asthma	0.000254	0.00027	CcSEcCtD
Deferoxamine—Infection—Prednisone—asthma	0.000253	0.000268	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Betamethasone—asthma	0.000252	0.000268	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Dexamethasone—asthma	0.000252	0.000268	CcSEcCtD
Deferoxamine—Hypersensitivity—Hydrocortisone—asthma	0.000252	0.000268	CcSEcCtD
Deferoxamine—Shock—Prednisone—asthma	0.00025	0.000266	CcSEcCtD
Deferoxamine—Pain—Betamethasone—asthma	0.00025	0.000265	CcSEcCtD
Deferoxamine—Pain—Dexamethasone—asthma	0.00025	0.000265	CcSEcCtD
Deferoxamine—Nervous system disorder—Prednisone—asthma	0.000249	0.000265	CcSEcCtD
Deferoxamine—Tachycardia—Prednisone—asthma	0.000248	0.000264	CcSEcCtD
Deferoxamine—Skin disorder—Prednisone—asthma	0.000247	0.000262	CcSEcCtD
Deferoxamine—Pruritus—Hydrocortisone—asthma	0.000242	0.000257	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Dexamethasone—asthma	0.000239	0.000254	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Betamethasone—asthma	0.000239	0.000254	CcSEcCtD
Deferoxamine—Hypersensitivity—Triamcinolone—asthma	0.000237	0.000252	CcSEcCtD
Deferoxamine—Hypersensitivity—Methylprednisolone—asthma	0.000237	0.000251	CcSEcCtD
Deferoxamine—Diarrhoea—Hydrocortisone—asthma	0.000234	0.000248	CcSEcCtD
Deferoxamine—Urticaria—Dexamethasone—asthma	0.000232	0.000246	CcSEcCtD
Deferoxamine—Urticaria—Betamethasone—asthma	0.000232	0.000246	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Prednisone—asthma	0.000232	0.000246	CcSEcCtD
Deferoxamine—Dizziness—Prednisolone—asthma	0.000231	0.000246	CcSEcCtD
Deferoxamine—Abdominal pain—Dexamethasone—asthma	0.000231	0.000245	CcSEcCtD
Deferoxamine—Body temperature increased—Dexamethasone—asthma	0.000231	0.000245	CcSEcCtD
Deferoxamine—Body temperature increased—Betamethasone—asthma	0.000231	0.000245	CcSEcCtD
Deferoxamine—Abdominal pain—Betamethasone—asthma	0.000231	0.000245	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALOX15—asthma	0.00023	0.00391	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ALOX5AP—asthma	0.00023	0.00391	CbGpPWpGaD
Deferoxamine—Paraesthesia—Prednisone—asthma	0.000228	0.000243	CcSEcCtD
Deferoxamine—Pruritus—Triamcinolone—asthma	0.000228	0.000242	CcSEcCtD
Deferoxamine—Pruritus—Methylprednisolone—asthma	0.000227	0.000241	CcSEcCtD
Deferoxamine—Dizziness—Hydrocortisone—asthma	0.000226	0.00024	CcSEcCtD
Deferoxamine—Diarrhoea—Methylprednisolone—asthma	0.00022	0.000233	CcSEcCtD
Deferoxamine—XDH—Metabolism—CHAT—asthma	0.00022	0.00373	CbGpPWpGaD
Deferoxamine—Headache—Prednisolone—asthma	0.000219	0.000233	CcSEcCtD
Deferoxamine—Vomiting—Hydrocortisone—asthma	0.000217	0.000231	CcSEcCtD
Deferoxamine—Headache—Hydrocortisone—asthma	0.000214	0.000227	CcSEcCtD
Deferoxamine—Dizziness—Triamcinolone—asthma	0.000213	0.000226	CcSEcCtD
Deferoxamine—Dizziness—Methylprednisolone—asthma	0.000212	0.000226	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Prednisone—asthma	0.000208	0.000221	CcSEcCtD
Deferoxamine—Nausea—Prednisolone—asthma	0.000208	0.000221	CcSEcCtD
Deferoxamine—Pruritus—Betamethasone—asthma	0.000207	0.00022	CcSEcCtD
Deferoxamine—Pruritus—Dexamethasone—asthma	0.000207	0.00022	CcSEcCtD
Deferoxamine—Vomiting—Triamcinolone—asthma	0.000205	0.000217	CcSEcCtD
Deferoxamine—Vomiting—Methylprednisolone—asthma	0.000204	0.000217	CcSEcCtD
Deferoxamine—Nausea—Hydrocortisone—asthma	0.000203	0.000216	CcSEcCtD
Deferoxamine—Urticaria—Prednisone—asthma	0.000202	0.000215	CcSEcCtD
Deferoxamine—Headache—Triamcinolone—asthma	0.000202	0.000214	CcSEcCtD
Deferoxamine—Headache—Methylprednisolone—asthma	0.000201	0.000214	CcSEcCtD
Deferoxamine—Abdominal pain—Prednisone—asthma	0.000201	0.000214	CcSEcCtD
Deferoxamine—Body temperature increased—Prednisone—asthma	0.000201	0.000214	CcSEcCtD
Deferoxamine—Diarrhoea—Dexamethasone—asthma	0.0002	0.000212	CcSEcCtD
Deferoxamine—Diarrhoea—Betamethasone—asthma	0.0002	0.000212	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALOX5—asthma	0.000196	0.00332	CbGpPWpGaD
Deferoxamine—Dizziness—Betamethasone—asthma	0.000193	0.000205	CcSEcCtD
Deferoxamine—Dizziness—Dexamethasone—asthma	0.000193	0.000205	CcSEcCtD
Deferoxamine—Nausea—Triamcinolone—asthma	0.000191	0.000203	CcSEcCtD
Deferoxamine—Nausea—Methylprednisolone—asthma	0.000191	0.000203	CcSEcCtD
Deferoxamine—Hypersensitivity—Prednisone—asthma	0.000187	0.000199	CcSEcCtD
Deferoxamine—XDH—Metabolism—CARM1—asthma	0.000187	0.00317	CbGpPWpGaD
Deferoxamine—Vomiting—Betamethasone—asthma	0.000186	0.000197	CcSEcCtD
Deferoxamine—Vomiting—Dexamethasone—asthma	0.000186	0.000197	CcSEcCtD
Deferoxamine—XDH—Metabolism—DCN—asthma	0.000184	0.00312	CbGpPWpGaD
Deferoxamine—Headache—Dexamethasone—asthma	0.000183	0.000194	CcSEcCtD
Deferoxamine—Headache—Betamethasone—asthma	0.000183	0.000194	CcSEcCtD
Deferoxamine—Pruritus—Prednisone—asthma	0.00018	0.000191	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALDH2—asthma	0.000179	0.00304	CbGpPWpGaD
Deferoxamine—Diarrhoea—Prednisone—asthma	0.000174	0.000185	CcSEcCtD
Deferoxamine—Nausea—Dexamethasone—asthma	0.000173	0.000184	CcSEcCtD
Deferoxamine—Nausea—Betamethasone—asthma	0.000173	0.000184	CcSEcCtD
Deferoxamine—XDH—Metabolism—GSTT1—asthma	0.00017	0.00289	CbGpPWpGaD
Deferoxamine—Dizziness—Prednisone—asthma	0.000168	0.000179	CcSEcCtD
Deferoxamine—Vomiting—Prednisone—asthma	0.000162	0.000172	CcSEcCtD
Deferoxamine—Headache—Prednisone—asthma	0.000159	0.000169	CcSEcCtD
Deferoxamine—Nausea—Prednisone—asthma	0.000151	0.00016	CcSEcCtD
Deferoxamine—XDH—Metabolism—NQO1—asthma	0.000142	0.0024	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ADCY2—asthma	0.000139	0.00235	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GSTP1—asthma	0.000118	0.002	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HMOX1—asthma	0.000116	0.00197	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ITPR1—asthma	0.000116	0.00197	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CAT—asthma	0.000115	0.00195	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PLA2G4A—asthma	0.000108	0.00184	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GSTM1—asthma	0.000108	0.00184	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPP2CA—asthma	9.99e-05	0.00169	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—POMC—asthma	7.67e-05	0.0013	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ALB—asthma	6.99e-05	0.00119	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NOS3—asthma	6.69e-05	0.00113	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PTGS2—asthma	6.12e-05	0.00104	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PTEN—asthma	5.33e-05	0.000905	CbGpPWpGaD
